TY - BOOK ID - 101127354 TI - Innovation in Drug Research and Development for Prevalent Chronic Diseases : Proceedings of a Workshop. AU - National Academies of Sciences, Engineering, and Medicine. AU - Division, Health and Medicine. AU - Policy, Board on Health Sciences. AU - Forum on Drug Discovery, Development, and Translation. AU - Shore, Carolyn. AU - Pool, Robert. AU - Gee, Amanda Wagner. AU - March, Andrew. AU - Forum on Drug Discovery, Development, and Translation AU - National Academies of Sciences, Engineering, and Medicine PY - 2022 SN - 0309092299 0309092396 PB - Washington, D.C. : National Academies Press, DB - UniCat KW - Medical Technology KW - Diseases KW - Medicine KW - Medical UR - https://www.unicat.be/uniCat?func=search&query=sysid:101127354 AB - Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as preventable suffering and death. On February 22, March 2, and March 8, 2021, the National Academies of Sciences, Engineering, and Medicine, convened a workshop to discuss barriers to innovation in this space and examine strategies and incentives to support equitable, person-centered drug R&D for prevalent chronic diseases. ER -